# OnCo record paper-bluemn-double-negative-prostate-fgf-mapk-cancer-cell-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bluemn-double-negative-prostate-fgf-mapk-cancer-cell-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bluemn-double-negative-prostate-fgf-mapk-cancer-cell-2017" ;
  schema:name "Androgen receptor pathway-independent prostate cancer is sustained through FGF signalling"@en ;
  schema:description "Over two decades a new kind of advanced prostate cancer appeared that uses neither the androgen receptor nor a neuroendocrine programme, and it runs on a growth factor pathway instead."@en ;
  schema:url <https://onco.cc/key-papers/paper-bluemn-double-negative-prostate-fgf-mapk-cancer-cell-2017/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.ccell.2017.09.003>, <https://pubmed.ncbi.nlm.nih.gov/29017058/> ;
  schema:sameAs <https://doi.org/10.1016/j.ccell.2017.09.003> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Bluemn EG, Coleman IM, Lucas JM, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/prostate-nepc/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/>, <https://onco.cc/targets/fgfr1/>, <https://onco.cc/targets/mek/> ;
  onco:pathways <https://onco.cc/pathways/ar-signaling/>, <https://onco.cc/pathways/fgfr-signalling/>, <https://onco.cc/pathways/ras-mapk/>, <https://onco.cc/pathways/lineage-plasticity-neuroendocrine/>, <https://onco.cc/pathways/resistance-routes-map/> ;
  onco:terms <https://onco.cc/terms/resistance/>, <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/histologic-transformation/> ;
  onco:journals <https://onco.cc/journals/cancer-cell/> .